H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 47 Citations 6,634 92 World Ranking 2456 National Ranking 1011

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Internal medicine

His scientific interests lie mostly in Mycobacterium tuberculosis, Immunology, Tuberculosis, Major histocompatibility complex and Antigen. His Mycobacterium tuberculosis research is multidisciplinary, incorporating perspectives in Inflammation, Interferon, Myeloid, Tuberculin and Vaccination. His work carried out in the field of Immunology brings together such families of science as Pharmacokinetics and Tuberculosis diagnosis.

His research integrates issues of Internal medicine, Disease and Immune system in his study of Tuberculosis. The various areas that W. Henry Boom examines in his Major histocompatibility complex study include Heat shock protein, Molecular biology and Antigen presentation. His biological study deals with issues like Virology, which deal with fields such as Pathogen, Bacterial antigen, Immunogenicity and Immunity.

His most cited work include:

  • A blood RNA signature for tuberculosis disease risk: a prospective cohort study. (397 citations)
  • Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors (267 citations)
  • Inhibition of IFN-γ-Induced Class II Transactivator Expression by a 19-kDa Lipoprotein from Mycobacterium tuberculosis: A Potential Mechanism for Immune Evasion (215 citations)

What are the main themes of his work throughout his whole career to date?

W. Henry Boom mainly investigates Mycobacterium tuberculosis, Tuberculosis, Immunology, Immune system and Microbiology. His studies in Mycobacterium tuberculosis integrate themes in fields like Genotype, Immunity, Antigen and Isoniazid. He combines subjects such as Internal medicine, Disease, Prospective cohort study and Vaccination with his study of Tuberculosis.

His Immunology study frequently draws connections to other fields, such as Virology. W. Henry Boom has included themes like Phagosome, Phagosome maturation, Mycobacterium bovis and Extracellular in his Microbiology study. His studies deal with areas such as T lymphocyte and Cell biology as well as T cell.

He most often published in these fields:

  • Mycobacterium tuberculosis (55.84%)
  • Tuberculosis (59.09%)
  • Immunology (48.05%)

What were the highlights of his more recent work (between 2017-2021)?

  • Mycobacterium tuberculosis (55.84%)
  • Tuberculosis (59.09%)
  • Immunology (48.05%)

In recent papers he was focusing on the following fields of study:

W. Henry Boom spends much of his time researching Mycobacterium tuberculosis, Tuberculosis, Immunology, Internal medicine and Immune system. His Mycobacterium tuberculosis study incorporates themes from Genetics, Phenotype, CD8, Microbiology and Tuberculin. His Microbiology research integrates issues from Phenylbutyrate, Cytokine, T cell, TLR2 and In vivo.

His Tuberculosis study integrates concerns from other disciplines, such as Single-nucleotide polymorphism, Disease, Gene and Vaccination. In general Internal medicine, his work in Cohort, Area under curve and Randomized controlled trial is often linked to Extramural linking many areas of study. His work focuses on many connections between Immune system and other disciplines, such as Flow cytometry, that overlap with his field of interest in Viral load and Clinical trial.

Between 2017 and 2021, his most popular works were:

  • Metabolite changes in blood predict the onset of tuberculosis (151 citations)
  • Four-gene pan-African blood signature predicts progression to tuberculosis (105 citations)
  • Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection. (86 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Internal medicine

W. Henry Boom mainly focuses on Tuberculosis, Mycobacterium tuberculosis, Internal medicine, Disease and Immunology. His study in the field of Tuberculin also crosses realms of Contact tracing. His work deals with themes such as Epidemiology, Interferon gamma release assay, Latent tuberculosis, Concordance and Asymptomatic, which intersect with Tuberculin.

His Mycobacterium tuberculosis research incorporates themes from Gene, Cohort and Risk of infection. The Internal medicine study combines topics in areas such as Drug resistance and MEDLINE. His study in Disease is interdisciplinary in nature, drawing from both Metabolite, Observational study, Active tb and Transmission.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A blood RNA signature for tuberculosis disease risk: a prospective cohort study.

Daniel E Zak;Adam Penn-Nicholson;Thomas J Scriba;Ethan Thompson.
The Lancet (2016)

423 Citations

Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors

Clifford V. Harding;W. Henry Boom.
Nature Reviews Microbiology (2010)

409 Citations

Inhibition of IFN-γ-Induced Class II Transactivator Expression by a 19-kDa Lipoprotein from Mycobacterium tuberculosis: A Potential Mechanism for Immune Evasion

Rish K. Pai;Marilyn Convery;Thomas A. Hamilton;W. Henry Boom.
Journal of Immunology (2003)

297 Citations

CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism.

David H. Canaday;Robert J. Wilkinson;Qing Li;Clifford V. Harding.
Journal of Immunology (2001)

241 Citations

Mycobacterium tuberculosis LprA Is a Lipoprotein Agonist of TLR2 That Regulates Innate Immunity and APC Function

Nicole D. Pecora;Adam J. Gehring;David H. Canaday;W. Henry Boom.
Journal of Immunology (2006)

238 Citations

Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages

David Stucki;David Stucki;Daniela Brites;Daniela Brites;Leïla Jeljeli;Mireia Coscolla;Mireia Coscolla.
Nature Genetics (2016)

229 Citations

Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-γ-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling

Meghan E. Pennini;Rish K. Pai;David C. Schultz;W. Henry Boom.
Journal of Immunology (2006)

219 Citations

Population Pharmacokinetics of Levofloxacin, Gatifloxacin, and Moxifloxacin in Adults with Pulmonary Tuberculosis

Charles A. Peloquin;David Jamil Hadad;Lucilia Pereira Dutra Molino;Moises Palaci.
Antimicrobial Agents and Chemotherapy (2008)

206 Citations

Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa.

Gillian F. Black;Bonnie A. Thiel;Martin O. Ota;Shreemanta K. Parida.
Clinical and Vaccine Immunology (2009)

175 Citations

TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis.

Michael G. Drage;Nicole D. Pecora;Amy G. Hise;Maria Febbraio.
Cellular Immunology (2009)

171 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing W. Henry Boom

Robert J. Wilkinson

Robert J. Wilkinson

The Francis Crick Institute

Publications: 90

Thomas J. Scriba

Thomas J. Scriba

University of Cape Town

Publications: 82

Tom H. M. Ottenhoff

Tom H. M. Ottenhoff

Leiden University Medical Center

Publications: 82

Sebastien Gagneux

Sebastien Gagneux

University of Basel

Publications: 74

Gerhard Walzl

Gerhard Walzl

Stellenbosch University

Publications: 70

Stefan H. E. Kaufmann

Stefan H. E. Kaufmann

Max Planck Institute for Infection Biology

Publications: 57

Willem A. Hanekom

Willem A. Hanekom

University College London

Publications: 49

Mihai G. Netea

Mihai G. Netea

Radboud University Nijmegen

Publications: 35

Joel D. Ernst

Joel D. Ernst

University of California, San Francisco

Publications: 34

Moses Joloba

Moses Joloba

Makerere University

Publications: 34

Clifton E. Barry

Clifton E. Barry

National Institutes of Health

Publications: 33

David M. Lewinsohn

David M. Lewinsohn

Oregon Health & Science University

Publications: 33

Laurent Abel

Laurent Abel

Inserm : Institut national de la santé et de la recherche médicale

Publications: 33

Alimuddin Zumla

Alimuddin Zumla

University College London

Publications: 32

Delia Goletti

Delia Goletti

Istituto Sperimentale Italiano Lazzaro Spallanzani

Publications: 32

Erwin Schurr

Erwin Schurr

McGill University Health Centre

Publications: 32

Something went wrong. Please try again later.